Improved anti-cancer effect of interferon gene transfer by sustained expression using CpG-reduced plasmid DNA
Open Access
- 18 May 2007
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 121 (2) , 401-406
- https://doi.org/10.1002/ijc.22636
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Reducing the immunostimulatory activity of CpG-containing plasmid DNA vectors for non-viral gene therapyExpert Opinion on Drug Delivery, 2004
- Long-term Transgene Expression from Plasmid DNA Gene Therapy Vectors Is Negatively Affected by CpG DinucleotidesMolecular Therapy, 2004
- CpG Methylation of a Plasmid Vector Results in Extended Transgene Product Expression by Circumventing Induction of Immune ResponsesMolecular Therapy, 2004
- CpG-Depleted Plasmid DNA Vectors with Enhanced Safety and Long-Term Gene Expression in VivoMolecular Therapy, 2002
- Efficient in vivo gene transfer by PCR amplified fragment with reduced inflammatory activityGene Therapy, 2001
- DNA methylation in health and diseaseNature Reviews Genetics, 2000
- Inhibition of Angiogenesis and Vascular Tumor Growth by Interferon-Producing Cells: A Gene Therapy ApproachThe American Journal of Pathology, 2000
- The Inhibitory Role of CpG Immunostimulatory Motifs in Cationic Lipid Vector-Mediated Transgene Expression in VivoHuman Gene Therapy, 1999
- Testing for the equality of area under the curves when using destructive measurement techniquesJournal of Pharmacokinetics and Biopharmaceutics, 1988
- Statistical moments in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1978